VISIBLE Clinical Trial Program

Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis

Osaka, Japan:  Interim analysis from VISIBLE OLE study showed long-term findings consistent with the known safety profile of vedolizumab with…

Read More »